MX2007000117A - Una composicion de combinacion. - Google Patents

Una composicion de combinacion.

Info

Publication number
MX2007000117A
MX2007000117A MX2007000117A MX2007000117A MX2007000117A MX 2007000117 A MX2007000117 A MX 2007000117A MX 2007000117 A MX2007000117 A MX 2007000117A MX 2007000117 A MX2007000117 A MX 2007000117A MX 2007000117 A MX2007000117 A MX 2007000117A
Authority
MX
Mexico
Prior art keywords
combination composition
combination
paracetamol
ibuprofen
pain
Prior art date
Application number
MX2007000117A
Other languages
English (en)
Spanish (es)
Inventor
Hartley Campbell Atkinson
Original Assignee
Aft Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aft Pharmaceuticals Ltd filed Critical Aft Pharmaceuticals Ltd
Publication of MX2007000117A publication Critical patent/MX2007000117A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Compounds Of Unknown Constitution (AREA)
MX2007000117A 2004-07-07 2005-07-07 Una composicion de combinacion. MX2007000117A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NZ53398204 2004-07-07
PCT/NZ2005/000168 WO2006004449A2 (en) 2004-07-07 2005-07-07 A combination composition

Publications (1)

Publication Number Publication Date
MX2007000117A true MX2007000117A (es) 2007-06-15

Family

ID=35783254

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2007000117A MX2007000117A (es) 2004-07-07 2005-07-07 Una composicion de combinacion.

Country Status (21)

Country Link
US (4) US20080275125A1 (cg-RX-API-DMAC7.html)
EP (1) EP1781277B1 (cg-RX-API-DMAC7.html)
JP (1) JP5630943B2 (cg-RX-API-DMAC7.html)
KR (1) KR101370712B1 (cg-RX-API-DMAC7.html)
CN (1) CN101022789A (cg-RX-API-DMAC7.html)
AT (1) ATE543491T1 (cg-RX-API-DMAC7.html)
AU (2) AU2005260243B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0512756A (cg-RX-API-DMAC7.html)
CA (1) CA2570474C (cg-RX-API-DMAC7.html)
CY (2) CY1112738T1 (cg-RX-API-DMAC7.html)
DK (1) DK1781277T3 (cg-RX-API-DMAC7.html)
ES (1) ES2381794T3 (cg-RX-API-DMAC7.html)
GB (1) GB2431346C (cg-RX-API-DMAC7.html)
LT (1) LTC1781277I2 (cg-RX-API-DMAC7.html)
MX (1) MX2007000117A (cg-RX-API-DMAC7.html)
PL (1) PL1781277T3 (cg-RX-API-DMAC7.html)
PT (1) PT1781277E (cg-RX-API-DMAC7.html)
RU (2) RU2007101686A (cg-RX-API-DMAC7.html)
SI (1) SI1781277T1 (cg-RX-API-DMAC7.html)
WO (1) WO2006004449A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA200700896B (cg-RX-API-DMAC7.html)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0512756A (pt) 2004-07-07 2008-04-08 Aft Pharmaceuticals Ltd composição farmacêutica de combinação para o tratamento de dor, método de controle de dor, uso de uma composição e embalagem farmacêutica incluindo comprimidos ou cápsulas
ZA200803566B (en) * 2005-12-12 2009-10-28 Adcock Ingram Ltd Pharmaceutical compositions
ES2651444T3 (es) * 2006-10-20 2018-01-26 Johnson & Johnson Consumer Inc. Combinación de acetaminofeno con ibuprofeno para el tratamiento del dolor
JP5676834B2 (ja) * 2006-11-29 2015-02-25 エスエス製薬株式会社 消化管への刺激性を減少した経口固形組成物
CA2731801C (en) * 2007-07-23 2013-11-26 Kingsway Pharmaceuticals Inc. Therapeutic formulations for the treatment of cold and flu-like symptoms
KR20110065417A (ko) * 2008-01-03 2011-06-15 욱크하르트 리미티드 파라세타몰 및 이부프로펜을 포함하는 경구 약제학적 현탁액
TR201906742T4 (tr) 2008-10-14 2019-05-21 Aft Pharmaceuticals Ltd Tıbbi bir ürün ve tedavi.
DE102010008876B4 (de) 2010-02-22 2017-07-27 Integrated Micro-Electronics Bulgaria Lichtquelle mit Array-LEDs zum direkten Betrieb am Wechselspannungsnetz und Herstellungsverfahren hierfür
NZ604009A (en) * 2010-07-07 2015-03-27 Aft Pharmaceuticals Ltd A combination composition comprising ibuprofen and paracetamol
ES2742373T3 (es) * 2010-11-04 2020-02-14 Aft Pharmaceuticals Ltd Una composición de combinación
BR112013028668A2 (pt) * 2011-05-06 2017-01-24 Glaxosmithkline Llc formulações de paracetamol de liberação sustentada
JP6009928B2 (ja) * 2012-12-14 2016-10-19 ダイハツ工業株式会社 車両のサスペンション
KR102373089B1 (ko) * 2017-03-30 2022-03-11 한미약품 주식회사 이부프로펜 및 아세트아미노펜을 포함하는 약제학적 조성물 및 이의 제조방법
EP4480495A3 (en) * 2017-07-10 2025-06-18 Gel Cap Technologies, LLC Dual release dosage form capsule and methods, devices and systems for making same
WO2019108147A1 (en) 2017-11-29 2019-06-06 İlko İlaç Sanayi̇ Ve Ti̇caret A.Ş. Color stable fixed dose tablet combination of ibuprofen and paracetamol
US11197830B2 (en) 2019-02-27 2021-12-14 Aft Pharmaceuticals Limited Pharmaceutical composition containing acetaminophen and ibuprofen
PH12021553169A1 (en) 2019-06-27 2022-08-15 Glaxosmithkline Consumer Healthcare Holdings Us Llc Novel ibuprofen and acetaminophen composition
WO2023281089A2 (en) 2021-07-08 2023-01-12 Krka, D.D., Novo Mesto Pharmaceutical composition comprising naproxen and paracetamol

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU605538B2 (en) * 1988-01-19 1991-01-17 Adcock Ingram Limited Pharmaceutical unit
CA1336687C (en) * 1989-08-23 1995-08-15 Thomas M. Tencza Process for preparing tablets containing ibuprofen, apap and caffeine, the products of this process and the use of such products
JP3122748B2 (ja) * 1991-11-29 2001-01-09 ライオン株式会社 イブプロフェン含有解熱鎮痛剤
US5409709A (en) * 1991-11-29 1995-04-25 Lion Corporation Antipyretic analgesic preparation containing ibuprofen
US5260337A (en) * 1992-07-29 1993-11-09 Merck & Co., Inc. Ibuprofen-muscle relaxant combinations
ZA959469B (en) 1994-11-15 1996-05-15 South African Druggists Ltd Pharmaceutical composition
KR970000231A (ko) * 1995-06-12 1997-01-21 박형미 진통소염제의 의약조성물
JP3982889B2 (ja) 1997-11-28 2007-09-26 あすか製薬株式会社 イブプロフェン含有医薬製剤
US6440983B1 (en) * 2000-12-21 2002-08-27 Mary Theresa Frank-Kollman Compositions and methods for relieving headache symptoms in aspirin-sensitive headache sufferers
BRPI0512756A (pt) 2004-07-07 2008-04-08 Aft Pharmaceuticals Ltd composição farmacêutica de combinação para o tratamento de dor, método de controle de dor, uso de uma composição e embalagem farmacêutica incluindo comprimidos ou cápsulas
GB0519350D0 (en) 2005-09-22 2005-11-02 Boots Healthcare Int Ltd Therapeutic agents
US20090264530A1 (en) 2008-04-16 2009-10-22 Nickell Robert P Combined nsaid and acetaminophen formulation and method
TR201906742T4 (tr) 2008-10-14 2019-05-21 Aft Pharmaceuticals Ltd Tıbbi bir ürün ve tedavi.

Also Published As

Publication number Publication date
CY1112738T1 (el) 2016-02-10
ATE543491T1 (de) 2012-02-15
ES2381794T3 (es) 2012-05-31
US20080200549A1 (en) 2008-08-21
CN101022789A (zh) 2007-08-22
EP1781277B1 (en) 2012-02-01
RU2007101686A (ru) 2008-08-20
GB2431346B (en) 2010-01-27
LTPA2024501I1 (cg-RX-API-DMAC7.html) 2024-02-12
WO2006004449A3 (en) 2006-03-02
EP1781277A4 (en) 2008-09-03
GB0700027D0 (en) 2007-02-07
GB2431346C (en) 2010-02-17
CY2023026I2 (el) 2025-03-28
RU2010147287A (ru) 2012-05-27
CA2570474A1 (en) 2006-01-12
CY2023026I1 (el) 2024-02-16
JP5630943B2 (ja) 2014-11-26
DK1781277T3 (da) 2012-05-07
WO2006004449A2 (en) 2006-01-12
SI1781277T1 (sl) 2012-07-31
US20080275125A1 (en) 2008-11-06
KR20070034614A (ko) 2007-03-28
US20110275718A1 (en) 2011-11-10
PL1781277T3 (pl) 2012-07-31
LTC1781277I2 (cg-RX-API-DMAC7.html) 2024-07-10
BRPI0512756A (pt) 2008-04-08
EP1781277A2 (en) 2007-05-09
AU2008202029A1 (en) 2009-11-26
US20140073696A1 (en) 2014-03-13
GB2431346A (en) 2007-04-25
AU2005260243B2 (en) 2009-10-29
PT1781277E (pt) 2012-05-07
ZA200700896B (en) 2008-07-30
CA2570474C (en) 2010-01-05
RU2455983C1 (ru) 2012-07-20
KR101370712B1 (ko) 2014-03-06
AU2005260243A1 (en) 2006-01-12
JP2008505889A (ja) 2008-02-28
US10532036B2 (en) 2020-01-14

Similar Documents

Publication Publication Date Title
CY1112738T1 (el) Μια συνδυασμενη συνθεση που περιεχει ιβουπροφαινη και παρακεταμολη
AR047841A1 (es) Metodos y composiciones para el tratamiento de transtornos inmunoinflamatorios
CY1118179T1 (el) Φαρμακευτικη συνθεση
ECSP056229A (es) Una composición farmacéutica que comprende formas polimórficas de 3-(4-amino-1-oxo-1.3 dyhidro-isoindol-2-il)-piperidina-2,6-diona para el tratamiento y manejo de cánceres
HN2002000275A (es) Derivados de 1,8 naftiridina y su uso para el tratamiento de diabetes y trastornos relacionados
AR054139A1 (es) Formulacion modificada y de liberacion inmediata de esferas de memantina
DE60336664D1 (de) Nichtnukleosidische reverse-transkriptase-hemmer
BG66093B1 (bg) Състави с контролирано освобождаване, съдържащи нимесулид
AR048833A1 (es) Procedimiento para el tratamiento de trastornos premenstruales y otros trastornos sexuales femeninos
UY27296A1 (es) Composición farmacéutica que contiene mosaprida y pancreatina
AR045572A1 (es) Una combinacion que comprende n-(3-metoxi-5-metilpirazin-2-il)-2-(4-[1,3,4-oxadiazol-2-il]fenil-3-sulfonamida y un analogo lhrh y/o un bifosfonato
BR112013010829B8 (pt) Composição farmacêutica intravenosa para proporcionar alívio da dor e/ou da inflamação
ATE499939T1 (de) Neue pharmazeutische zusammenstezungen, flibanserin polymorph a enthaltend
MX2007009032A (es) Formulacion para inyeccion de butanos catecolicos incluyendo compuestos ndga en animales.
AR028448A1 (es) Formulaciones que contienen una droga glucocorticoide para el tratamiento de enfermedades broncopulmonares
AR046402A1 (es) Combinacion de principio activo que comprende un compuesto 2,5-dihidrobencenosulfonico y un modulador de los canales de potasio
CL2004001421A1 (es) Composicion farmaceutica que comprende un compuesto derivado de 1,4-dipiperidin-4-il-piperazina; y su uso para la prevencion y/o tratamiento del dolor.
CL2008001477A1 (es) Composicion farmaceutica compuesta por la combinacion sinergica de un agente anticonvulsivante como gabapentina y un agente antiinflamatorio no esteroideo como meloxicam, los rangos de concentracion presentes para la gabapentina son 3 a 300 mg y de 0,1 a 30 mg para meloxicam; y uso para tratar el dolor neuropatico
CL2008000965A1 (es) Composicion farmaceutica que comprende un agente antiinflamatorio no esteroideo y un analgesico opiaceo, y su uso para el tratamiento del dolor.
MXPA02010828A (es) Composicion farmaceutica en capsulas que comprende un antiinflamatorio no esteroideo y un analgesico opiaceo para el manejo del dolor.
AR043016A2 (es) Un compuesto antimigranico eletriptan y composicion farmaceutica que lo contiene
SE0203817D0 (sv) New composition
AR067351A1 (es) Combinacion de picotamida con nafronil
AR030660A1 (es) Composicion farmaceutica para la prevencion o el tratamiento de una enfermedad asociada con un exceso de la produccion de il-12
MY154883A (en) A combination composition

Legal Events

Date Code Title Description
FG Grant or registration